Straits Times Index
3,410.04 +42.14 (+1.25%) Nikkei
40,373.67 +298.98 (+0.75%) Hang Seng
17,917.74 +148.60 (+0.84%) FTSE 100
8,121.20 -45.56 (-0.56%) Bitcoin USD
61,432.05 -1,553.85 (-2.47%) CMC Crypto 200
1,322.57 -21.94 (-1.63%)
AGC Inc (SHJ.DU)
| Previous close | 29.80 |
| Open | 29.80 |
| Bid | 30.60 x 0 |
| Ask | 31.20 x 0 |
| Day's range | 29.80 - 30.40 |
| 52-week range | 29.60 - 35.60 |
| Volume | |
| Avg. volume | 5 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireThe AGC Group Obtains Its First Cradle to Cradle Certified® for Mirox MNGE Interior Glass Products in Asia
TOKYO, May 13, 2024--AGC Glass Asia’s Mirox MNGE, a low lead mirror, is awarded with Cradle to Cradle Certified® at the Bronze level based on version 3.1.
Business WireThe AGC Group Makes Donations to Help Victims of Eastern Taiwan Earthquake
TOKYO, April 19, 2024--The AGC Group had announced that it will donate 3 million yen to help those affected by the eastern Taiwan Earthquake.
- MediaOutReach
AGC Biologics Announces Plans for New Manufacturing Site in Yokohama Japan
The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026SEATTLE, USA - News Direct - 04 January 2024 - AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC Inc.’s Yokohama Technical Center in Japan. The new site is a part of the CDMO’s strategic growth strategy to create more high-quali
